医学
围手术期
红细胞压积
安慰剂
麻醉
重组因子VIIa
外科
巴曲酶
肝切除术
输血
纤维蛋白原
内科学
切除术
病理
替代医学
作者
J.P.A. Lodge,Sven Jonas,Élie Oussoultzoglou,Massimo Malagò,Christian Jayr,Daniel Cherqui,Matthias Anthuber,Darius F. Mirza,L Kuhlman,Wolf O. Bechstein,Juan Carlos Menéu Díaz,J. Tartière,Daniel Eyraud,Marianne Fridberg,Elisabeth Erhardtsen,Olivier Mimoz
出处
期刊:Anesthesiology
[Lippincott Williams & Wilkins]
日期:2005-01-19
卷期号:102 (2): 269-275
被引量:198
标识
DOI:10.1097/00000542-200502000-00006
摘要
Recombinant factor VIIa dosing did not result in a statistically significant reduction in either the number of patients transfused or the volume of blood products administered. No safety issues were identified.
科研通智能强力驱动
Strongly Powered by AbleSci AI